Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
v3etfV71rmaeQAwJ